RESUMO
The contraceptive efficacy and clinical performance of Nova-T and TCu200Ag were studied in a randomized comparative study with 819 interval acceptors. The 1- and 2-year gross termination rates were evaluated by means of the life-table method. The 12-month pregnancy rates were 1.0 per 100 women with Nova-T and 3.0 per 100 women with TCu200Ag. The preliminary 2-year rates were 1.7 and 5.5 per 100 respectively (p = 0.037). Rates of expulsion, medical and personal removals were not significantly different for the two devices. Continuation rates for the first year were 89.4 and 90.5 per 100 respectively.
Assuntos
Dispositivos Intrauterinos de Cobre , Adulto , Ensaios Clínicos como Assunto , Feminino , Humanos , Gravidez , Distribuição AleatóriaRESUMO
Actinomyces-like organisms (ALO) were found in 6.9% of cervical smears in 2133 IUD users. The chance of having co-infection with Trichomonas vaginalis was 2.7 times higher in women with ALO than in ALO negative women. The proportion of IUD users with ALO in cervical smears increased with the duration of the IUD use. A total of 108 IUD users with ALO were compared with the same number of IUD users without ALO in cervical smears. The women in the two groups were matched for the duration of the IUD use. During the IUD use the women with ALO had PID and vaginitis significantly more frequently than ALO negative women. No difference was found regarding the type of the IUD used in women with ALO in cervical smears compared to controls.
Assuntos
Actinomicose/etiologia , Colo do Útero/microbiologia , Dispositivos Intrauterinos/efeitos adversos , Doenças do Colo do Útero/etiologia , Actinomyces/isolamento & purificação , Adulto , Feminino , Humanos , Vaginite por Trichomonas/etiologiaRESUMO
The effect of oral contraceptive use on the development of severe dysplasia, carcinoma in situ and invasive carcinoma of the cervix was studied by a prospective longitudinal survey of 32,000 women. They were enrolled into the study between the ages of 15 and 39. Some had started oral contraceptive use before enrollment, others started after enrollment and some remained non-users throughout the study period. They were followed-up to 6-1/2 years. Analyses were performed on data from 24,784 women who met our criteria for incidence. Data were adjusted for years of follow-up, age at enrollment, age at first pregnancy, number of pregnancies, number of smears, and duration of use.
